FDA-Drug2013-09-04Class II
Benztropine Mesylate Injection, USP, 2 mg/mL(1 mg/1 mL), 2 mL Single Dose Vial, Rx only, Manufactured in the USA for Nexus Pharmaceuticals Inc, Lincolnshire, IL 60069, NDC 14789-300-02
Nexus Pharmaceuticals Inc
Hazard
Presence of particulate matter: characterized as thin colorless flakes that are visually and chemically consistent with glass delamination.
Sold states
Nationwide
Affected count
46,185 vials
Manufactured in
175 E Hawthorn Pkwy Ste 155, Vernon Hills, IL, United States
Products
Benztropine Mesylate Injection, USP, 2 mg/mL(1 mg/1 mL), 2 mL Single Dose Vial, Rx only, Manufactured in the USA for Nexus Pharmaceuticals Inc, Lincolnshire, IL 60069, NDC 14789-300-02
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-925-2013Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief